Improving Efficacy of Diabetes Management Using Treatment Algorithms in a Mainly Hispanic Population
Table 2—
Treatment regimens at the end of 12 months
| Medications | CC-TA | UC-TA | CC-SC |
|---|---|---|---|
| n | 106 | 170 | 82 |
| Diabetes | |||
| Initial treatment (100%) | |||
| Glucotrol XL | 96 (91) | 167 (98) | 48 (59) |
| Chlorpropamide | 0 | 0 | 9 (11) |
| Glyburide | 0 | 0 | 15 (18) |
| Metformin | 0 | 0 | 8 (10) |
| Diet and exercise | 10 (9) | 3 (2) | 2 (2) |
| Final treatment (100%) | |||
| Glucotrol XL | 75 (71) | 104 (61) | 34 (42) |
| Glucotrol XL/metformin | 19 (18) | 55 (32) | 20 (25) |
| Glucotrol XL/metformin + insulin | 0 | 3 (2) | 1 (1) |
| Chlorpropamide | 0 | 0 | 1 (1) |
| Glyburide | 0 | 0 | 6 (7) |
| Metformin | 0 | 0 | 13 (16) |
| Insulin | 0 | 0 | 2 (2) |
| Diet and exercise | 12 (11) | 8 (5) | 5 (6) |
| Hypertension | |||
| Initial treatment (100%) | |||
| Monopril | 40 (38) | 93 (55) | 23 (28) |
| Benazepril | 0 | 0 | 6 (7) |
| Captopril | 0 | 0 | 2 (2) |
| Diltiazem-SR | 0 | 0 | 3 (4) |
| Enalapril | 0 | 0 | 7 (9) |
| None | 66 (62) | 77 (45) | 41 (50) |
| Final treatment (100%) | |||
| Monopril | 37 (35) | 79 (47) | 24 (29) |
| Monopril/diltiazem-SR | 3 (3) | 14 (8) | 7 (9) |
| Monopril/diltiazem/hydrochlorothiazide | 0 | 0 | 4 (5) |
| Vera pamil | 0 | 0 | 2 (2) |
| None | 66 (62) | 77 (45) | 45 (55) |
| Dyslipidemia | |||
| Initial treatment (100%) | |||
| Pravastatin | 31 (29) | 29 (17) | 2 (2) |
| Gemfibrozil | 7 (7) | 16 (9) | 9 (11) |
| Simvastatin | 0 | 0 | 4 (6) |
| Lovastatin | 0 | 0 | 2 (2) |
| None | 68 (64) | 125 (74) | 65 (79) |
| Final treatment (100%) | |||
| Pravastatin | 31 (29) | 29 (17) | 2 (2) |
| Gemfibrozil | 8 (8) | 16 (9) | 7 (9) |
| Simvastatin | 0 | 0 | 3 (4) |
| Lovastatin | 0 | 0 | 2 (2) |
| None | 67 (63) | 125 (74) | 68 (83) |
-
Data are n (%).
CiteULike
Delicious
Digg
Facebook
Google+
Reddit
Technorati
Twitter
This Article
-
Diabetes Care July 2004 vol. 27 no. 7 1638-1646
Current Issue
From the Cover
- Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
- Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program
- High fat intake leads to acute postprandial exposure to circulating endotoxin in type 2 diabetic subjects
- Type 1 diabetes increases the expression of proinflammatory cytokines and adhesion molecules in the artery wall of candidate patients for kidney transplantation
